March 17, 2023
2 min watch
Supply/Disclosures
Revealed by:
Supply:
Koerber N. 5-year medical effectiveness of ab-interno canaloplasty in managed and uncontrolled glaucoma sufferers. Offered at: European Society of Cataract and Refractive Surgeons winter assembly; March 10-12, 2023; Vilamoura, Portugal.
Disclosures:
Koerber studies no related monetary disclosures.
We have been unable to course of your request. Please strive once more later. For those who proceed to have this difficulty please contact customerservice@slackinc.com.
Key takeaways:
- Norbert Koerber, MD, PhD, mentioned 5-year outcomes of ab interno canaloplasty.
- Outcomes confirmed important IOP discount, significantly in sufferers with uncontrolled IOP earlier than surgical procedure.
VILAMOURA, Portugal — On the ESCRS winter assembly, Norbert Koerber, MD, PhD, introduced the 5-year knowledge of ab interno canaloplasty in sufferers with main open-angle glaucoma.
“We had a big strain discount, particularly within the group with uncontrolled IOP earlier than surgical procedure, of about 40%,” he mentioned. “We anticipate that the outcomes shall be secure for some extra years.”
We have been unable to course of your request. Please strive once more later. For those who proceed to have this difficulty please contact customerservice@slackinc.com.
